Collects blood and tumor samples from people having colorectal cancer surgery
Follows surgery outcomes and collects samples from adults with colorectal cancer.
Plain-language title generated from the registry record
Registry title: Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer
Key facts
- Where
- Stavanger, NorwaySee the site
Where in Norway
- Stavanger University HospitalStavanger, NorwayTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Helse Stavanger HF
- Trial code
- NCT01762813
- Record updated
- 30 April 2026
- Original description
* A prospective, observational study on clinical outcomes of surgical management of primary and metastatic colorectal cancer * Prospective collection of tissues to explore potential biomarkers in blood and/or primary or secondary cancers and/or normal colonRead full original descriptionShow less
Prospective, Population-based Cohort Collection of Blood Samples and Tumor Tissue From Patients Operated on for Primary or Metastatic Colorectal Cancer
* A prospective, observational study on clinical outcomes of surgical management of primary and metastatic colorectal cancer * Prospective collection of tissues to explore potential biomarkers in blood and/or primary or secondary cancers and/or normal colon
Inclusion: Diagnosis of colorectal cancer, primary or metastatic (liver), with a treatment intention of planned curative surgery; Informed consent to participate; Age ≥18.
Exclusion: failure to provide written informed consent.